DaVita has launched a value-based care partnership with Humana to provide coordinated care for over 10,000 Medicare Advantage members with chronic kidney disease stages 3B–5. The program focuses on early intervention to slow disease progression, reduce hospitalizations, and improve patient outcomes by addressing kidney health alongside related conditions. This approach includes education, advance care planning, and support for treatment options like home dialysis and transplantation. The initiative builds on DaVita's extensive nephrologist network and aims to improve quality of life and care experience for patients at risk of kidney failure.
Alebund Pharmaceuticals announced significant progress in H1 2026, including completion of patient enrollment for its AP301 Phase III trial and acceptance of its New Drug Application for AP301 by China's NMPA. The company saw a 761.2% revenue increas...
AllianceBernstein Global High Income Fund, Inc. released its July 31, 2026 portfolio update, showing total net assets of $970.77 million and a net asset value of $11.26 per share. The fund holds a diversified portfolio of 1,190 fixed-income securitie...
